According to The European Community Capital Landscape 2025 analysis of ECSP-authorized platforms across the continent, 𝗖𝗮𝗽𝗶𝘁𝗮𝗹 𝗖𝗲𝗹𝗹 𝗿𝗮𝗻𝗸𝘀 #𝟭 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲 𝗯𝘆 𝘁𝗼𝘁𝗮𝗹 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝗿𝗮𝗶𝘀𝗲𝗱 𝗶𝗻 𝟮𝟬𝟮𝟱.

Across Europe, Life Sciences is the sector with the highest number of successful campaigns and the most capital raised, confirming the growing investor appetite for deep-tech, science-driven innovation.

At Capital Cell, this has been our focus from the beginning: building a platform dedicated to Life Sciences and health innovation, connecting startups with a community of investors who want to support the long-term value of scientific breakthroughs.

The European community capital market is evolving quickly:

• More cross-border participation

• Larger and more structured rounds

• Increasing involvement of professional investors

• Stronger sector specialization

𝗪𝗲’𝗿𝗲 𝗽𝗿𝗼𝘂𝗱 𝘁𝗼 𝗰𝗼𝗻𝘁𝗿𝗶𝗯𝘂𝘁𝗲 𝘁𝗼 𝘁𝗵𝗶𝘀 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗴𝗿𝗮𝘁𝗲𝗳𝘂𝗹 𝘁𝗼 𝘁𝗵𝗲 𝗳𝗼𝘂𝗻𝗱𝗲𝗿𝘀, 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿𝘀, 𝗮𝗻𝗱 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝘄𝗵𝗼 𝗺𝗮𝗸𝗲 𝗶𝘁 𝗽𝗼𝘀𝘀𝗶𝗯𝗹𝗲.

Discover more insights in the European Community Capital Landscape 2025 report: https://communitycapital.eu/